Sign in

CIK 0001790340

  • Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
  1. 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 2,551 shares at $3.92 ($10,000)
  2. 4 Open-market buy GENERAL COUNSEL AND SECRETARY bought 1,000 shares at $4.88 ($4,880)
  3. 4 Open-market buy Director bought 7,000 shares at $5.00 ($35,000)
  4. 4 Open-market buy CFO, TREASURER bought 1,000 shares at $4.42 ($4,420)
  5. 4 Exercise or conversion PRESIDENT AND CEO acquired 2,000 shares (option exercise)
  6. 4 Open-market buy PRESIDENT AND CEO bought 3,000 shares at $8.02 ($24,060)
  7. 4 Open-market buy CHIEF SCIENTIFIC OFFICER bought 1,050 shares at $7.91 ($8,306)
  8. 4 Open-market buy CHIEF MEDICAL OFFICER bought 900 shares at $7.49 ($6,737)
  9. 4 Open-market buy Director bought 6,667 shares at $6.75 ($45,002)
  10. 4 Open-market buy Director bought 6,000 shares at $6.40 ($38,400)
  11. 4 Exercise or conversion PRESIDENT AND CEO acquired 2,000 shares (option exercise)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 5 Insider Annual Insider Trading Report
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 322,691 shares (grant or award)

Page 7 of 9 · 166 filings